Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shexiang Haima Zhuifeng Gao (麝香海马追风膏) is an approved traditional Chinese medicine (TCM) topical plaster developed and manufactured by Chongqing Healn Pharmaceutical. The formulation consists of 21 active ingredients, including artificial musk, seahorse, raw nux vomica, and various herbal extracts such as angelica, safflower, and frankincense, along with camphor and methyl salicylate. It is pharmacologically designed to dispel wind and cold, promote blood circulation, and alleviate pain. The product is primarily indicated for the treatment of numbness resulting from wind-cold, lower back and leg pain, and limb numbness. It is applied topically as a rubber-based plaster and is marketed under the brand names Wushufang and Wushu'an.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shexiang Haima Zhuifeng Gao.